Naomi Taylor pursued her MD/ PhD studies at Yale University School of Medicine followed by Pediatrics training at Yale New Haven Hospital and the Childrens Hospital of Los Angeles Bone Marrow Transplantation Program. She is presently Senior Investigator and Director of Basic-to-Translational Research in the Pediatric Oncology Branch of the National Cancer Institute. She also maintains an adjunct Professor position at the University of Montpellier, Institut de Génétique Moléculaire, in France where she began her research group in 1997. Her group’s expertise in T cell-based gene/cell therapies, metabolic regulation of normal and malignant hematopoiesis and thymus differentiation have been internationally recognized, and their data has promoted the development of optimized T-cell based immunotherapy protocols for cancer patients. Furthermore, the group’s recent studies on the interplay between metabolite transporters and fuel choice have resulted in the identification of new metabolic programs regulating erythropoiesis, physiological and pathological hematopoietic lineage commitment and modulation of T cell effector function in the context of anti-tumor immunotherapies.